Inventor · disambiguated record
Warren Wade
Also filed as: WADE WARREN · WADE WARREN S · WADE WARREN STANFIELD
33 granted patents·13 pending applications·210 citations·filing 2004–2025
97Inventor score
Files withNEUROCRINE BIOSCIENCES INC15CAMPBELL DAVID6BEATON GRAHAM4JANSSEN PHARMACEUTICA NV4AFRAXIS INC2
Top patents by PatentIndex Score
46 records- 0195US7419983B2Gonadotropin-releasing hormone receptor antagonists and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2007·Granted Sep 2, 2008·38 cites·40 claims
- 0294US9422310B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2015·Granted Aug 23, 2016·14 cites·19 claims
- 0394US7176211B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Feb 13, 2007·32 cites·20 claims
- 0493US7056927B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Jun 6, 2006·49 cites·45 claims
- 0589US8084614B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2008·Granted Dec 27, 2011·12 cites·17 claims
- 0687US7229995B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Jun 12, 2007·10 cites·20 claims
- 0785US10941159B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2019·Granted Mar 9, 2021·1 cites·4 claims
- 0885US8481738B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2011·Granted Jul 9, 2013·6 cites·9 claims
- 0984US9693992B2IRE-1α inhibitorsMANNKIND CORP·Filed 2015·Granted Jul 4, 2017·4 cites·10 claims
- 1083US10336769B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2017·Granted Jul 2, 2019·2 cites·1 claims
- 1183US8952161B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2013·Granted Feb 10, 2015·4 cites·16 claims
- 1282US11787798B2Aryl piperidines as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 17, 2023·1 cites·18 claims
- 1382US9040714B2IRE-1α inhibitorsZENG QINGPING·Filed 2011·Granted May 26, 2015·6 cites·2 claims
- 1480US7015226B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Mar 21, 2006·12 cites·28 claims
- 1579US8674095B2Compounds for treating neuropsychiatric conditionsCAMPBELL DAVID·Filed 2009·Granted Mar 18, 2014·4 cites·7 claims
- 1678US9867803B2IRE-1α inhibitorsSHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD·Filed 2017·Granted Jan 16, 2018·2 cites·28 claims
- 1777US8372970B28-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disordersAFRAXIS INC·Filed 2010·Granted Feb 12, 2013·4 cites·15 claims
- 1876US11713324B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Aug 1, 2023·0 cites·2 claims
- 1976US8680099B26-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disordersCAMPBELL DAVID·Filed 2011·Granted Mar 25, 2014·2 cites·55 claims
- 2076US2025282792A1Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2175US8912203B26-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disordersCAMPBELL DAVID·Filed 2011·Granted Dec 16, 2014·1 cites·32 claims
- 2274US10357475B2IRE-1α inhibitorsFOSUN ORINOVE PHARMATECH INC·Filed 2017·Granted Jul 23, 2019·1 cites·13 claims
- 2374US10100045B23-aryl-2H-pyrazolo[4,3-b]pyridine compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 16, 2018·1 cites·16 claims
- 2472US11337956B2IRE-1α inhibitorsFOSUN ORINOVE PHARMATECH INC·Filed 2019·Granted May 24, 2022·0 cites·9 claims
- 2571US10087185B2Fused bicylic pyridine compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 2, 2018·1 cites·26 claims
- 2669US12508267B2Isotopically-labelled trapidil derivativesSINOPIA BIOSCIENCES INC·Filed 2022·Granted Dec 30, 2025·0 cites·10 claims
- 2769US2024092781A1Aryl piperidines as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2868US9493435B2IRE-1α inhibitorsZENG QINGPING·Filed 2010·Granted Nov 15, 2016·1 cites·17 claims
- 2957US9946847B2Libraries of compounds having desired properties and methods for making and using themBIOBLOCKS INC·Filed 2013·Granted Apr 17, 2018·1 cites·16 claims
- 3056US8263588B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2008·Granted Sep 11, 2012·0 cites·18 claims
- 3155US7067509B2Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Jun 27, 2006·1 cites·59 claims
- 3254US2018072745A1IRE-1alpha INHIBITORSSHANGHAI FOSUN PHARMACEUTICAL NDUSTRIAL DEV CO LTD·Filed 2017·Application pending·0 cites
- 3351US9856266B2IRE-1alpha inhibitorsSHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD·Filed 2016·Granted Jan 2, 2018·0 cites·17 claims
- 3451US9725426B2Cystathionine-γ-lyase (CSE) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2013·Granted Aug 8, 2017·0 cites·19 claims
- 3550US7378552B2Monoamine re-uptake inhibitors and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2006·Granted May 27, 2008·0 cites·15 claims
- 3648US8507536B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2012·Granted Aug 13, 2013·0 cites·16 claims
- 3748US2018300461A1Libraries of compounds having desired properties and methods for making and using themBIOBLOCKS INC·Filed 2018·Application pending·0 cites
- 3847US2013035335A18-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disordersAFRAXIS INC·Filed 2012·Application pending·0 cites
- 3946US2016024083A1Compounds and methods for treating cancersHEALTH RESEARCH INC·Filed 2014·Application pending·0 cites
- 4046US2016368872A1Compounds and methods for treating cancersHEALTH RESEARCH INC·Filed 2014·Application pending·0 cites
- 4145US2013338153A18-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disordersCAMPBELL DAVID·Filed 2011·Application pending·0 cites
- 4243US2017327478A1Cystathionine-gamma-lyase (cse) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4340US2006252818A1Monoamine re-uptake inhibitors and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2006·Application pending·0 cites
- 4440US2005256124A1Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Application pending·0 cites
- 4539US2013252967A18-(sulfonylbenzyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disordersCAMPBELL DAVID·Filed 2011·Application pending·0 cites
- 4639US2013231348A18-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERSCAMPBELL DAVID·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Warren Wade files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →